Skip to main content
Article
Prolonged survival in objective responders to ipilimumab therapy.
Journal of Clinical Oncology (2008)
  • J. D. Powderly, Medarex
  • S. J. O’Day, University of California, Los Angeles
  • E. M. Hersh, University of Arizona
  • S. Tchekmedyian
  • F. S. Hodi
  • G. Nichol, Medarex
  • M. J. Yellin, Medarex
  • W. J. Urba, Vanderbilt University
  • W. E. Samlowski, Nevada Cancer Institute
  • J. S. Weber, University of Washington
Publication Date
May 20, 2008
DOI
10.1200/jco.2008.26.15_suppl.20004
Citation Information
J. D. Powderly, S. J. O’Day, E. M. Hersh, S. Tchekmedyian, et al.. "Prolonged survival in objective responders to ipilimumab therapy." Journal of Clinical Oncology Vol. 26 (2008) p. 20004 - 20004
Available at: http://works.bepress.com/walter-urba/7/